Conexeu Sciences is trading at $3.66, down 7.34%, with no clear catalyst confirmed.

  • No company announcement dated October 16 was found; its latest listed release was the October 15 private placement.
  • The placement raised approximately $5 million through units priced at $3.00, each including a share and warrant; the announcement does not establish that it caused the decline.
  • Broader-market context is mixed: Nasdaq is down 0.61%, while the Dow is up 0.55%.